Shock wave lithotripsy: a randomized, double-blind trial to compare immediate versus delayed voltage escalation
Urology · 2010 · Vol. 75 · Issue 1 · 38-43
Academy Summary
Shock wave lithotripsy: a randomized, double-blind trial to compare immediate versus delayed voltage escalation examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Treatment Optimisation.
The investigators used a Randomized Double-Blind Trial in adults undergoing swl. This design strengthens comparison between the treatment strategies studied, although the conclusions still remain tied to the lithotripter, protocol and eligibility criteria used.
A randomized double-blind study compared immediate with delayed voltage escalation and found higher treatment success with immediate escalation in the studied protocol, without a clear complication penalty.
Energy ramping is not simply a comfort manoeuvre. It is a method of designing the biological and mechanical dose of SWL.
This study contributes to the evidence that the sequence in which shock-wave energy is delivered can influence both stone comminution and renal tissue response. The objective is to reach effective fragmentation energy while limiting unnecessary renal vascular and parenchymal stress.
Published in 2010, the study predates several contemporary refinements in SWL technique. The clinical principle remains relevant, but absolute rates and machine settings should be interpreted in their technological era.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
